Patients with clinically isolated syndromes (CIS) are prone to develop multiple sclerosis (MS). The randomized, placebo-controlled CHAMPS trial found early treatment with interferon -1a to be ...

Gilenya and Tascenso ODT are approved to treat relapsing forms of multiple sclerosis (MS) in adults. Gilenya and Tascenso ODT ...

Novartis today announced full results from the positive Phase III PARADIGMS study, investigating the safety and efficacy of Gilenya ® (fingolimod) vs. interferon beta-1a, in children and adolescents ...

Medically reviewed by Brigid Dwyer, MD Key Takeaways Disease-modifying therapies slow down the progression of multiple ...

Rebif is a brand-name liquid solution that’s typically self-injected. It’s prescribed for certain forms of multiple sclerosis (MS) and contains the active ingredient interferon beta-1a. It is not ...